Safety and Immunogenicity of High-dose IN-B001 in Healthy Subjects

NCT04637919 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Hand, Foot and Mouth Disease

Interventions

BIOLOGICAL: IN-B001 EV71 A dose
BIOLOGICAL: IN-B001 CVA16 B dose
BIOLOGICAL: IN-B001 Bivalent C dose
BIOLOGICAL: Placebo

Sponsor

HK inno.N Corporation